Skip to content


More than a 100-year experience with drug development and discovery
We work relentlessly to help patients with skin diseases. We are driven by our desire to offer new, innovative medicines better and faster than anyone else, and our aspiration is to help 125 million patients by 2025.
Kim Kjøller
Executive Vice President
Global Research

At LEO Pharma Research & Development (R&D), we pioneer dermatology by driving science to discover and develop new innovative solutions for the treatment of psoriasis, eczema and rare diseases as one of the world’s leading companies within medical dermatology.

We push the limits of medical dermatology to understand patients, skin and dermatological diseases better than anyone else to pave the way towards precision medicine, prevention and eventually curing skin diseases.

LEO Pharma invests heavily in R&D and 18% of our turnover is allocated to research and development of new innovative solutions.

Our research organization is situated at our headquarters in Ballerup, Denmark closely collaborating with industry partners around the world as well as with our development organization and our Science & Tech Hubs in Boston, US and Tokyo, Japan.

Our global development organization is situated in Madison, US and Ballerup Denmark respectively.

We drive our research and development projects in multi-disciplinary and cross-functional project teams integrating advanced knowledge in R&D disciplines with expertise in clinical practices and therapeutic needs.